David Domzalski - 31 Mar 2022 Form 4 Insider Report for VYNE Therapeutics Inc. (VYNE)

Role
President and CEO, Director
Signature
/s/ Mutya Harsch, attorney-in-fact for David Domzalski
Issuer symbol
VYNE
Transactions as of
31 Mar 2022
Net transactions value
-$15,071
Form type
4
Filing time
04 Apr 2022, 17:08:45 UTC
Previous filing
18 Mar 2022
Next filing
02 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VYNE Common Stock Tax liability $15,071 -23,186 -2.2% $0.6500 1,049,749 31 Mar 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.